# Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00982891** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 45 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Opioid (morphine sulphate) in low dose

## Key facts

- **NCT ID:** NCT00982891
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-01-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982891, "Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00982891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*